Literature DB >> 20937721

Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation.

Sander Verheule1, Els Tuyls, Arne van Hunnik, Marion Kuiper, Ulrich Schotten, Maurits Allessie.   

Abstract

BACKGROUND: Over a time course of months, the stability of atrial fibrillation (AF) gradually increases and the efficacy of pharmacological cardioversion declines both in humans and in animal models. Changes in fibrillatory conduction over this period largely are unexplored. METHODS AND RESULT: Goats were instrumented with an atrial endocardial pacemaker lead and a burst pacemaker. AF was maintained for 3 weeks (short-term AF [ST], n = 10) or 6 months (long-term AF [LT], n = 7). AF could be cardioverted pharmacologically at the early time point (persistent AF), but not at the later time point (permanent AF). At follow-up, a high-resolution mapping electrode was used to record epicardial conduction patterns in the free walls of the right atrium (RA) and left atrium (LA). A new method for mapping of fibrillation waves was used to describe AF conduction patterns. Wavefronts propagated uniformly during slow pacing in both groups, although conduction velocity was significantly lower in the LT group (LA, 93 ± 14 versus 72 ± 10 cm/s; RA, 94 ± 8 versus 78 ± 8 cm/s). Median AF cycle length (AFCL) was not significantly different between the groups. However, the LT group showed highly complex activation patterns during AF, with an increased number of simultaneously propagating waves (LT group RA, 8.4 ± 3.0 waves/AFCL; LA, 12.8 ± 2.4 waves/AFCL; versus ST group RA, 4.3 ± 2.2 waves/AFCL; LA, 4.5 ± 2.5 waves/AFCL). Fibrillation waves in the LT group showed pronounced dissociation with large activation time differences. The incidence of waves newly appearing within the recording area also was increased in both atria. These alterations in conduction were accompanied by myocyte hypertrophy and increased endomysial fibrosis.
CONCLUSIONS: Long-term AF in goats leads to dissociated conduction in the atrial free walls that may contribute to increased AF stability.

Entities:  

Mesh:

Year:  2010        PMID: 20937721     DOI: 10.1161/CIRCEP.109.931634

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  33 in total

1.  Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Authors:  Michael A Rosenberg; Marlena Maziarz; Alex Y Tan; Nicole L Glazer; Susan J Zieman; Jorge R Kizer; Joachim H Ix; Luc Djousse; David S Siscovick; Susan R Heckbert; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

Review 2.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 3.  Catheter Ablation Targeting Complex Fractionated Atrial Electrogram in Atrial Fibrillation.

Authors:  Dennis H Lau; Stef Zeemering; Bart Maesen; Pawel Kuklik; Sander Verheule; Ulrich Schotten
Journal:  J Atr Fibrillation       Date:  2013-10-31

4.  [Catheter ablation of persistent and long-standing persistent atrial fibrillation. Strategies and results].

Authors:  Daniel Steven; Arian Sultan; Benjamin Schäffer; Helge Servatius; Boris Hoffmann; Jakob Lüker; Stephan Willems
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-04-30

5.  Diagnostic imaging and pacemaker implantation in a domestic goat with persistent left cranial vena cava.

Authors:  Ravi Ranjan; Derek Dosdall; Layne Norlund; Koji Higuchi; Joshua M Silvernagel; Aaron L Olsen; Christopher J Davies; Rob MacLeod; Nassir F Marrouche
Journal:  J Vet Cardiol       Date:  2013-12-25       Impact factor: 1.701

Review 6.  Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

Authors:  Paulus Kirchhof; Gregory Y H Lip; Isabelle C Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kaab; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Axel Brandes; Michael Ezekowitz; Hans Diener; Laurent Haegeli; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Maria Aunes-Jansson; Carina Blomstrom-Lundqvist; Maria Borentain; Stefanie Breitenstein; Martina Brueckmann; Nilo Cater; Andreas Clemens; Dobromir Dobrev; Sergio Dubner; Nils G Edvardsson; Leif Friberg; Andreas Goette; Michele Gulizia; Robert Hatala; Jenny Horwood; Lukas Szumowski; Lukas Kappenberger; Josef Kautzner; Angelika Leute; Trudie Lobban; Ralf Meyer; Jay Millerhagen; John Morgan; Felix Muenzel; Michael Nabauer; Christoph Baertels; Michael Oeff; Dieter Paar; Juergen Polifka; Ursula Ravens; Ludger Rosin; W Stegink; Gerhard Steinbeck; Panos Vardas; Alphons Vincent; Maureen Walter; Günter Breithardt; A John Camm
Journal:  Europace       Date:  2011-07-26       Impact factor: 5.214

7.  The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation.

Authors:  Takashi Ashihara; Ryo Haraguchi; Kazuo Nakazawa; Tsunetoyo Namba; Takanori Ikeda; Yuko Nakazawa; Tomoya Ozawa; Makoto Ito; Minoru Horie; Natalia A Trayanova
Journal:  Circ Res       Date:  2011-12-15       Impact factor: 17.367

8.  Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs.

Authors:  Derek J Dosdall; Ravi Ranjan; Koji Higuchi; Eugene Kholmovski; Nathan Angel; Li Li; Rob Macleod; Layne Norlund; Aaron Olsen; Christopher J Davies; Nassir F Marrouche
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-28       Impact factor: 4.733

9.  Impact of baseline atrial fibrillation cycle length on acute and long-term outcome of persistent atrial fibrillation ablation.

Authors:  S Ammar; G Hessling; M Paulik; T Reents; R Dillier; A Buiatti; V Semmler; C Kolb; B Haller; I Deisenhofer
Journal:  J Interv Card Electrophysiol       Date:  2014-07-10       Impact factor: 1.900

Review 10.  Experimental Evidence Of The Role Of Renal Sympathetic Denervation For Treating Atrial Fibrillation.

Authors:  Dominik Linz; Christian Ukena; Milan Wolf; Benedikt Linz; Felix Mahfoud; Michael Böhm
Journal:  J Atr Fibrillation       Date:  2014-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.